Anuh Pharma Ltd.
ANUHPHR.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.75B
Close$
$105.07
27.9% upside
Current Fair Value
27.9% upsideUndervalued by 27.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.75 Billion |
|---|---|
| Enterprise Value | $8.75 Billion |
| Annual dividend | $1.50 |
| Dividend yield | 1.72% |
| Earnings per Share | $4.1 |
| Beta | 0.43 |
| Outstanding Shares | 100,224,000 |
Return
| Return on Equity | 12.54% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 19.8 |
|---|---|
| PEG | 52.61 |
| Price to Sales | 1.07 |
| Price to Book Ratio | 2.35 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | 15.25 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Anuh Pharma Limited
323 employees
CEO: Ritesh Bipin Shah
Established on February 19, 1960, Anuh Pharma Limited is a Mumbai, India-based pharmaceutical enterprise. The company's operations involve the creation of a diverse array of medicinal chemicals, botanical derivatives, and pharmaceutical ...